501 related articles for article (PubMed ID: 9916987)
1. The inhibitors of apoptosis (IAPs) and their emerging role in cancer.
LaCasse EC; Baird S; Korneluk RG; MacKenzie AE
Oncogene; 1998 Dec; 17(25):3247-59. PubMed ID: 9916987
[TBL] [Abstract][Full Text] [Related]
2. The inhibitors of apoptosis (IAPs) as cancer targets.
Hunter AM; LaCasse EC; Korneluk RG
Apoptosis; 2007 Sep; 12(9):1543-68. PubMed ID: 17573556
[TBL] [Abstract][Full Text] [Related]
3. Coexistence of high levels of apoptotic signaling and inhibitor of apoptosis proteins in human tumor cells: implication for cancer specific therapy.
Yang L; Cao Z; Yan H; Wood WC
Cancer Res; 2003 Oct; 63(20):6815-24. PubMed ID: 14583479
[TBL] [Abstract][Full Text] [Related]
4. Targeting of X-linked inhibitor of apoptosis protein or survivin by short interfering RNAs sensitize hepatoma cells to TNF-related apoptosis-inducing ligand- and chemotherapeutic agent-induced cell death.
Yamaguchi Y; Shiraki K; Fuke H; Inoue T; Miyashita K; Yamanaka Y; Saitou Y; Sugimoto K; Nakano T
Oncol Rep; 2005 Nov; 14(5):1311-6. PubMed ID: 16211302
[TBL] [Abstract][Full Text] [Related]
5. ch-IAP1, a member of the inhibitor-of-apoptosis protein family, is a mediator of the antiapoptotic activity of the v-Rel oncoprotein.
You M; Ku PT; Hrdlicková R; Bose HR
Mol Cell Biol; 1997 Dec; 17(12):7328-41. PubMed ID: 9372964
[TBL] [Abstract][Full Text] [Related]
6. IAP-family protein survivin inhibits caspase activity and apoptosis induced by Fas (CD95), Bax, caspases, and anticancer drugs.
Tamm I; Wang Y; Sausville E; Scudiero DA; Vigna N; Oltersdorf T; Reed JC
Cancer Res; 1998 Dec; 58(23):5315-20. PubMed ID: 9850056
[TBL] [Abstract][Full Text] [Related]
7. Inhibitor of apoptosis proteins are regulated by tumour necrosis factor-alpha in malignant pleural mesothelioma.
Gordon GJ; Mani M; Mukhopadhyay L; Dong L; Yeap BY; Sugarbaker DJ; Bueno R
J Pathol; 2007 Mar; 211(4):439-46. PubMed ID: 17253597
[TBL] [Abstract][Full Text] [Related]
8. Identification of v-Rel oncogene-induced inhibitor of apoptosis by differential display.
You M; Bose HR
Methods; 1998 Dec; 16(4):373-85. PubMed ID: 10049645
[TBL] [Abstract][Full Text] [Related]
9. Neutralization of Smac/Diablo by inhibitors of apoptosis (IAPs). A caspase-independent mechanism for apoptotic inhibition.
Wilkinson JC; Wilkinson AS; Scott FL; Csomos RA; Salvesen GS; Duckett CS
J Biol Chem; 2004 Dec; 279(49):51082-90. PubMed ID: 15371416
[TBL] [Abstract][Full Text] [Related]
10. Expression patterns of inhibitor of apoptosis proteins in malignant pleural mesothelioma.
Gordon GJ; Mani M; Mukhopadhyay L; Dong L; Edenfield HR; Glickman JN; Yeap BY; Sugarbaker DJ; Bueno R
J Pathol; 2007 Mar; 211(4):447-54. PubMed ID: 17253596
[TBL] [Abstract][Full Text] [Related]
11. Caenorhabditis elegans inhibitor of apoptosis protein (IAP) homologue BIR-1 plays a conserved role in cytokinesis.
Fraser AG; James C; Evan GI; Hengartner MO
Curr Biol; 1999 Mar; 9(6):292-301. PubMed ID: 10209096
[TBL] [Abstract][Full Text] [Related]
12. Dual apoptotic effect of Xrel3 c-Rel/NF-kappaB homolog in human cervical cancer cells.
Shehata M; Shehata M; Shehata F; Pater A
Cell Biol Int; 2004; 28(12):895-904. PubMed ID: 15566959
[TBL] [Abstract][Full Text] [Related]
13. Ubiquitin binding modulates IAP antagonist-stimulated proteasomal degradation of c-IAP1 and c-IAP2(1).
Blankenship JW; Varfolomeev E; Goncharov T; Fedorova AV; Kirkpatrick DS; Izrael-Tomasevic A; Phu L; Arnott D; Aghajan M; Zobel K; Bazan JF; Fairbrother WJ; Deshayes K; Vucic D
Biochem J; 2009 Jan; 417(1):149-60. PubMed ID: 18939944
[TBL] [Abstract][Full Text] [Related]
14. Mathematical modeling of the regulation of caspase-3 activation and degradation.
Stucki JW; Simon HU
J Theor Biol; 2005 May; 234(1):123-31. PubMed ID: 15721041
[TBL] [Abstract][Full Text] [Related]
15. Caspase-3 and inhibitor of apoptosis protein(s) interactions in Saccharomyces cerevisiae and mammalian cells.
Wright ME; Han DK; Hockenbery DM
FEBS Lett; 2000 Sep; 481(1):13-8. PubMed ID: 10984607
[TBL] [Abstract][Full Text] [Related]
16. IAPs contain an evolutionarily conserved ubiquitin-binding domain that regulates NF-kappaB as well as cell survival and oncogenesis.
Gyrd-Hansen M; Darding M; Miasari M; Santoro MM; Zender L; Xue W; Tenev T; da Fonseca PC; Zvelebil M; Bujnicki JM; Lowe S; Silke J; Meier P
Nat Cell Biol; 2008 Nov; 10(11):1309-17. PubMed ID: 18931663
[TBL] [Abstract][Full Text] [Related]
17. Inhibitor of apoptosis proteins and their relatives: IAPs and other BIRPs.
Verhagen AM; Coulson EJ; Vaux DL
Genome Biol; 2001; 2(7):REVIEWS3009. PubMed ID: 11516343
[TBL] [Abstract][Full Text] [Related]
18. ML-IAP, a novel inhibitor of apoptosis that is preferentially expressed in human melanomas.
Vucic D; Stennicke HR; Pisabarro MT; Salvesen GS; Dixit VM
Curr Biol; 2000 Nov; 10(21):1359-66. PubMed ID: 11084335
[TBL] [Abstract][Full Text] [Related]
19. Regulation of apoptosis proteins in cancer cells by ubiquitin.
Zhang HG; Wang J; Yang X; Hsu HC; Mountz JD
Oncogene; 2004 Mar; 23(11):2009-15. PubMed ID: 15021888
[TBL] [Abstract][Full Text] [Related]
20. MAP kinase-dependent, NF-kappaB-independent regulation of inhibitor of apoptosis protein genes by TNF-alpha.
Furusu A; Nakayama K; Xu Q; Konta T; Kitamura M
J Cell Physiol; 2007 Mar; 210(3):703-10. PubMed ID: 17133355
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
